What a CGM can show you about your hormones
A single fasting blood draw is one frame of a very long film. A continuous glucose monitor plays the whole reel — and in our practice, two weeks of that data often explains symptoms a “normal” lab never could.
What a CGM measures
A continuous glucose monitor — CGM — is a small sensor worn on the back of the upper arm. A tiny filament sits just under the skin and reads the glucose in the surrounding fluid every few minutes, around the clock, for about two weeks.
The difference from a standard blood draw is not precision — it’s continuity. Instead of one number taken at one fasting moment, you get a moving line: how your blood sugar rises and falls with each meal, each walk, each stressful afternoon, and each night’s sleep. As we explain in blood sugar and your cycle, those after-meal swings are exactly the part a fasting glucose can miss.
The same person, one day: a flat fasting line, a sharp spike and crash after lunch, an overnight low, then a much flatter curve when a meal is followed by a walk. This is what a CGM makes visible.
Patterns we see in practice
In our own patients, the same handful of patterns come up again and again — and they are almost never visible on a single fasting lab:
- Big post-meal spikes with “normal” labs. A fasting glucose in range, paired with steep rises after ordinary meals — the exact swings that drive the energy crash and cravings women describe.
- Overnight lows. Dips in the small hours that can pull someone out of sleep at 3 a.m. — often mistaken for a stress or hormone problem alone.
- Stress responses. Glucose climbing during a tense meeting or a poor night’s sleep, with no food involved — a vivid reminder that blood sugar isn’t only about diet.
- The same meal, two different responses. A breakfast that’s calm on a rested day and spikes on a short-sleep day — showing how sleep and stress change the picture.
Seeing your own line do these things is often more persuasive than any explanation. It turns an abstract idea — “insulin may be part of this” — into something you can watch happen.
How the data informs a plan
A CGM isn’t the point in itself — it’s a two-week window that makes the plan specific to you. Because the data is personal, the changes can be too:
- We can see which of your meals spike and which stay steady — so adjustments target real culprits, not generic rules.
- We can test small levers in real time — a walk after lunch, protein before carbs, an earlier dinner — and watch whether the curve flattens.
- We can connect the glucose story to the rest of the picture — androgens, cycles, and the pattern driving a given case of PCOS / PMOS.
The goal isn’t to chase a perfectly flat line or to fear food. It’s to learn how your body responds, and to build a routine that fits it.
Who benefits from a trial
A CGM isn’t necessary for everyone, but a short trial can be genuinely clarifying if you:
- Have irregular cycles alongside cravings, energy crashes, or skin changes
- Have been told your labs are “normal” but don’t feel it
- Carry a PCOS/PMOS diagnosis and want to understand your metabolic side
- Learn best by seeing your own data rather than being handed a rule sheet
In our practice, a CGM is one tool we can add to a work-up when the case calls for it — not a requirement, and not a substitute for the full clinical picture.
The honest limits
CGMs are powerful, but they aren’t perfect, and it’s worth naming what they can’t do:
- They measure glucose in skin fluid, not blood directly, so readings lag slightly and single values can be off — the trend is what matters, not any one point.
- They show glucose, not insulin — so they complement labs like fasting insulin rather than replacing them.
- Watching the number can tip into anxiety for some people; the aim is insight, not vigilance.
Used well — for a defined stretch, with a clinician to help read it — a CGM turns two weeks of ordinary life into a map. That map is only useful next to the rest of your story, which is exactly how we use it.
Common questions
References (3) ▾
- Continuous glucose monitoring: accuracy, interstitial lag, and interpretation — clinical review. [Reference to be finalized on publish.]
- Glycemic variability and post-prandial glucose responses in non-diabetic adults — review. [Reference to be finalized on publish.]
- International evidence-based guideline for the assessment and management of polycystic ovary syndrome. 2023.
A short CGM trial is one of the tools we can add to a work-up when it fits your case — alongside the labs and the full picture that tell us which pattern is driving your symptoms.